Request to Join
has invited you to join this group
Joslyn Kirby received her MD from the University of Virginia and completed her dermatology residency training at the University of Pennsylvania and is currently an Associate Professor at Penn State Hershey Medical Center. After practicing as a general dermatologist for 5 years, she returned to school and completed Masters degrees in Public Health Sciences as well as Education. Her professional interests are split among clinical care, research, and education. Her work has focused on several skin conditions – acne, rosacea, and hidradenitis suppurativa – as well as actinic keratosis. Her research often investigates the costs of care, including drugs, venues of care, and alternative payment models.
Aaron S. Kesselheim, M.D., J.D., M.P.H., is an Associate Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital. His research focuses on the effects of intellectual property laws and regulatory policies on pharmaceutical development, the drug approval process, and the costs, availability, and use of prescription drugs both domestically and in resource-poor settings. Within the Division, Dr. Kesselheim leads the Program On Regulation, Therapeutics, And Law (PORTAL), an interdisciplinary research core focusing on intersections among prescription drugs and medical devices, patient health outcomes, and regulatory practices and the law. Dr. Kesselheim’s work is currently funded by the Greenwall Faculty Scholars in Bioethics, Laura and John Arnold Foundation, the FDA and the Harvard Program in Therapeutic Science. Dr. Kesselheim has testified before Congress on pharmaceutical policy, medical device regulation, generic drugs, and modernizing clinical trials, and served as a consultant for the NIH, FDA, Institute of Medicine, USPTO, and numerous state government offices. Dr. Kesselheim also serves as a faculty supervisor for the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, a faculty member of the Harvard Center for Bioethics, and a Research Associate in the Department of Health Policy and Management at the Harvard School of Public Health. In the 2016-2017 academic year, he has been a Visiting Associate Professor of Law at Yale Law School, where taught Food and Drug Administration Law. He graduated from Harvard College and received his postgraduate training at the University of Pennsylvania School of Medicine and Law School, and most recently at the Harvard School of Public Health. He is Board Certified in Internal Medicine, and serves as a primary care physician at the Phyllis Jen Center for Primary Care at BWH.
Harlan Krumholz is a cardiologist, health care scientist, and health care improvement expert at Yale University where he is the Harold H. Hines, Jr. Professor of Medicine. He is Director of the Yale-New Haven Hospital Center for Outcomes Research and Evaluation and Co-Director of the Robert Wood Johnson Foundation Clinical Scholars Program at Yale. His has led research and initiatives to improve the quality and outcomes of clinical decisions and health care delivery, reduce disparities, enable transparency in practice and research, and avoid wasteful practices. His team is guiding federal efforts to measure and promote health care value. He began the Yale Open Data Access Project to promote data sharing and open science. He founded Hugo, a mobile app to empower people with their health-related data, promoting the possibility of a consumer-mediated information platform. He is a founding member of the Board of Governors of the Patient-Centered Outcomes Research Institute. Dr. Krumholz received a BS from Yale, an MD from Harvard Medical School, and a Masters in Health Policy and Management from the Harvard University School of Public Health.
Kirsten Bibbins-Domingo, PhD, MD, MAS, is the Lee Goldman, MD Endowed Chair in Medicine and Professor of Medicine and of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF). She is the Director of the UCSF Center for Vulnerable Populations, a research center focused on chronic disease prevention in at-risk communities. She leads the Cardiovascular Disease Policy Model (CVD Policy Model) team at UCSF that uses simulation modeling to examine the health and cost implications of clinical and public health interventions aimed at prevention. Dr. Bibbins-Domingo is a recognized expert in evidence-based prevention. She is the Chair of the US Preventive Services Task Force and has been a member for over 5 years. She also is an inducted member of the American Society for Clinical Investigation and the National Academy of Medicine.
Kashif’s inspiration in life comes from his family members who happen to be educators, engineers and physicians settled across England, United States, Canada and Pakistan. After attending the Aga Khan University Medical College in the coastal city of Karachi, he moved to Houston to attend the Internal Medicine Residency Program at The University of Texas Health Science Center. Later on, he decided to pursue hospitalist medicine at a health underserved area in Central Florida. He accepted a chief resident year 2016-2017 at a fairly new Internal Medicine Residency Program the University of Central Florida, College of Medicine. He is a Harry Potter fan who grew up reading Jane Austin and Bronte. He played Chess and Badminton avidly while participating in various extra-curricular activities in school. He enjoys listening to Billie Holiday, Ella Fitzgerald, Chopin, Beethoven and Bach. He is a car enthusiast and loves road trips to nearby beaches of sunny Florida. Some of his interests include history, museums, art galleries, live theater, short films, historic cities, documentaries, charity events and current affairs. His future plans include applying for rheumatology fellowship, academic medicine, charity and volunteer work.